Latest News about Breast Cancer
Recent news which mentions Breast Cancer
From Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
March 10, 2022
Tickers
NVS
From Benzinga
From Benzinga
From PRLog
From PRLog
Puma Biotech's Nerlynx Included In NCCN Guidelines For Breast Cancer
January 13, 2022
Tickers
PBYI
From Benzinga
From Benzinga
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
December 10, 2021
From Benzinga
Context Therapeutics Shares Surge On Encouraging Data From Onapristone In Early Breast Cancer
December 10, 2021
Tickers
CNTX
From Benzinga
Seagen Tukysa Maintains Survival Benefit, Delays Cancer Progression In The Brain In Breast Cancer Patients
December 09, 2021
Tickers
SGEN
From Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
December 08, 2021
Tickers
NVS
From Benzinga
Radius Health Reveals Detailed Elacestrant Data From Late-Stage Breast Cancer Trial
December 08, 2021
Tickers
RDUS
From Benzinga
After Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
November 30, 2021
Tickers
OLMA
From Benzinga
From Benzinga
Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer
November 23, 2021
Tickers
MRK
From Benzinga
QView Medical maintains leadership position in AI-powered breast cancer screening technology through alliance with GE Healthcare
November 23, 2021
From PRLog
Athenex To Present Subgroup Analysis Of Oral Paclitaxel-Encequidar Combo Data From Breast Cancer Trial
November 22, 2021
Tickers
ATNX
From Benzinga
Jaguar Health's Posts Crofelemer Data For Chemo-Induced Diarrhea In Breast Cancer Patients
November 19, 2021
Tickers
JAGX
From Benzinga
QView Medical in Support of Breast Cancer Awareness Month Joins the Initiative of AmIDense.com
October 18, 2021
Tickers
ABUS
From PRLog
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.